Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Acupressure for COVID-19 Related Quality of Life and Stress

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04472559
Recruitment Status : Recruiting
First Posted : July 15, 2020
Last Update Posted : June 18, 2021
Sponsor:
Information provided by (Responsible Party):
Kakit P. Hui, MD, University of California, Los Angeles

Brief Summary:
This study is being conducted to evaluate the efficacy of acupressure in promoting health and well-being among healthcare workers during the COVID-19 pandemic. The investigators hypothesize that providing participants with a remote and standardized self-acupressure training program will improve HRQOL and the perception of stress. In the event that the study demonstrates acupressure to be safe and effective for this indication, the training could be scaled up and deployed at low-cost nationally and internationally.

Condition or disease Intervention/treatment Phase
Quality of Life Stress Behavioral: Self-acupressure Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 200 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Randomized Controlled Trial of Acupressure for Health-Related Quality of Life and Perception of Stress Among Health Care Providers During the COVID-19 Pandemic
Actual Study Start Date : June 16, 2021
Estimated Primary Completion Date : October 1, 2021
Estimated Study Completion Date : December 25, 2021

Arm Intervention/treatment
Experimental: Self-acupressure Behavioral: Self-acupressure
Self-acupressure

No Intervention: Control



Primary Outcome Measures :
  1. Health Related Quality of Life [ Time Frame: 8 weeks ]
    SF-12v2

  2. Perception of stress [ Time Frame: 8 weeks ]
    Perceived Stress Scale



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • All adult patients (18 years of age and over) who are health care providers according to self-report will be eligible for participation with the exception of subjects meeting exclusion criteria as below.

Exclusion Criteria:

  • Exclusion criteria includes subjects who are physically unable to participate (e.g., from severe arthritis) or cognitively unable to participate (e.g., from dementia) will be excluded. Patients unable to provide their own informed consent will be excluded. Patients under the age of 18 years will be excluded. Pregnant women will be excluded. Patients who have previous training in acupressure will be excluded.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04472559


Contacts
Layout table for location contacts
Contact: Ryan Abbott, MD, PhD 310-794-0712 rabbott@mednet.ucla.edu

Locations
Layout table for location information
United States, California
UCLA Recruiting
Los Angeles, California, United States, 90024
Contact: Ryan B Abbott, MD, PhD         
Sponsors and Collaborators
University of California, Los Angeles
Investigators
Layout table for investigator information
Principal Investigator: Ka-Kit Hui, MD University of California, Los Angeles
Layout table for additonal information
Responsible Party: Kakit P. Hui, MD, Professor, University of California, Los Angeles
ClinicalTrials.gov Identifier: NCT04472559    
Other Study ID Numbers: 20-000773
First Posted: July 15, 2020    Key Record Dates
Last Update Posted: June 18, 2021
Last Verified: June 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No